Intrathecal application of the nimodipine slow-release microparticle system EG-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn 120, Issue , 2015, Pages 281-286

  Etminan, Nima ^a   Loch Macdonald, R ^b,c   Davis, Cara ^d   Burton, Kevin ^d   Steiger, Hans Jakob ^a   Hänggi, Daniel ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Evonik Industries   (United States)

Author keywords

Delayed cerebral ischemia; EG 1962 microparticle system; Intrathecal application; Subarachnoid hemorrhage

Indexed keywords

DIHYDROPYRIDINE DERIVATIVE; EG 1962; NICARDIPINE; NIMODIPINE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; MICROSPHERE; VASODILATOR AGENT;

ARTICLE; BRAIN ISCHEMIA; DELAYED CEREBRAL ISCHEMIA; HUMAN; MULTICENTER STUDY (TOPIC); NONHUMAN; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SLOW RELEASE FORMULATION; SUBARACHNOID HEMORRHAGE; ADMINISTRATION AND DOSAGE; COMPLICATION; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; INTRASPINAL DRUG ADMINISTRATION;

BRAIN ISCHEMIA; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; INJECTIONS, SPINAL; MICROSPHERES; NIMODIPINE; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS;

EID: 84921664308     PISSN: 00651419     EISSN: 21978395     Source Type: Book Series    
DOI: 10.1007/978-3-319-04981-6_47     Document Type: Article

References (34)

1. Lovelock CE, Rinkel GJ, Rothwell PM (2010) Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology 74: 1494-1501.
2. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J et al (2009) Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 132: 1866-1881.
3. Ohkuma H, Manabe H, Tanaka M, Suzuki S (2000) Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31: 1621-1627.
4. Park KW, Metais C, Dai HB, Comunale ME, Sellke FW (2001) Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg 92: 990-996.
5. Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and-independent effects. Stroke 42: 924-929.
6. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB (2008) Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28: 1761-1770.
7. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 31: 1443-1451.
8. Etminan N, Vergouwen MDI, Macdonald RL (2013) Angiographic vasospasm versus cerebral infarction as outcome measures after subarachnoid hemorrhage. Acta Neurochir Suppl 115: 33-40.
9. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (3): CD000277.
10. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J (1998) Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50: 876-883.
11. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S et al (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (conscious-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39: 3015-3021.
12. Vergouwen MD, Etminan N, Ilodigwe D, Macdonald RL (2011) Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 31: 1545-1553.
13. Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F (2008) Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens 30: 744-766.
14. Vergouwen MD, Vermeulen M, de Haan RJ, Levi M, Roos YB (2007) Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review. J Cereb Blood Flow Metab 27: 1293-1308.
15. Radhakrishnan D, Menon DK (1997) Haemodynamic effects of intravenous nimodipine following aneurysmal subarachnoid haemorrhage: implications for monitoring. Anaesthesia 52: 489-491.
16. Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC (2010) Effect of different components of triple-h therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 14: R23.
17. Barth M, Capelle HH, Weidauer S, Weiss C, Munch E, Thome C et al (2007) Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, doubleblind phase IIa study. Stroke 38: 330-336.
18. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP (1994) A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg 80: 788-796.
19. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T (2005) Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 56: 895-902, discussion 895-902.
20. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T (2002) Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 33: 1011-1015.
21. Rosenberg N, Lazzaro MA, Lopes DK, Prabhakaran S (2011) High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit Care 15: 400-404.
22. Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K (1994) Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 131: 19-25.
23. Webb A, Kolenda J, Martin K, Wright W, Samuels O (2010) The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care 12: 159-164.
24. Hanggi D, Beseoglu K, Turowski B, Steiger HJ (2008) Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Clin Neurol Neurosurg 110: 784-790.
25. Hanggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ (2009) A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Cen Eur Neurosurg 70: 61-67.
26. Zhang YP, Shields LB, Yao TL, Dashti SR, Shields CB (2013) Intrathecal treatment of cerebral vasospasm (2012). J Stroke Cerebrovasc Dis 22(8): 1201-1211.
27. Barth M, Pena P, Seiz M, Thome C, Muench E, Weidauer S et al (2011) Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage. Br J Neurosurg 25: 677-683.
28. Kasuya H (2011) Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo. Acta Neurochir Suppl 110: 165-167.
29. Lemperle G, Morhenn VB, Pestonjamasp V, Gallo RL (2004) Migration studies and histology of injectable microspheres of different sizes in mice. Plast Reconstr Surg 113: 1380-1390.
30. Nicholas AP, McInnis C, Gupta KB, Snow WW, Love DF, Mason DW et al (2002) The fate of biodegradable microspheres injected into rat brain. Neurosci Lett 323: 85-88.
31. Toyota BD (1999) The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage. J Neurosurg 90: 203-206.
32. Bege N, Renette T, Endres T, Beck-Broichsitter M, Hanggi D, Kissel T (2013) In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm. Eur J Pharm Biopharm 84: 99-105.
33. Cook DJ, Kan S, Ai J, Kasuya H, Macdonald RL (2012) Cisternal sustained release dihydropyridines for subarachnoid hemorrhage. Curr Neurovasc Res 9: 139-148.
34. Hanggi D, Perrin J, Eicker S, Beseoglu K, Etminan N, Kamp MA et al (2012) Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage. PLoS One 7: e42597.